Acticor Biotech SAS announced the postponement of the publication of its annual results and universal registration document including its 2023 annual financial report, originally scheduled for April 30, 2024. The company will issue a release announcing the new date of approval and publication of the 2023 financial statements by the Board of Directors, as well as that of the annual financial report included in the 2023 Universal Registration Document.